معرفی
Dr. Claire Jennings is a researcher at Newcastle University, specializing in pharmacology, oncology, and molecular biology. Her work focuses on drug discovery targeting protein-protein interactions, cancer therapy development, and structural mechanisms in bacterial biology. She has collaborated extensively on studies involving MDM2 antagonists, NF-κB-inducing kinase inhibition, and peptidoglycan biosynthesis regulation.
Research interests include:
- Pharmacology and computational modeling of ligand binding
- Targeted cancer therapies for NPM1-mutated AML
- Covalent and stapled peptide drug design
- Mechanistic insights into bacterial protein phosphorylation
Recent publications emphasize small molecule antagonists (2024), nucleolar stress responses (2021), and cysteine-editing strategies (2019). Collaborators include Professor Gareth Veal (2021), Professor Martin Noble (2019), and colleagues in chemical biology and microbiology.
۰مقاله منتشرشده